↓ Skip to main content
What is this page? Embed badge

HIV Vaccines and Cure

Overview of attention for book
Cover of 'HIV Vaccines and Cure'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 HIV Vaccine Efficacy Trials: RV144 and Beyond
  3. Altmetric Badge
    Chapter 2 HIV T-Cell Vaccines
  4. Altmetric Badge
    Chapter 3 HIV Broadly Neutralizing Antibodies: VRC01 and Beyond
  5. Altmetric Badge
    Chapter 4 Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine
  6. Altmetric Badge
    Chapter 5 Monkey Models and HIV Vaccine Research
  7. Altmetric Badge
    Chapter 6 Treatment of HIV for the Prevention of Transmission in Discordant Couples and at the Population Level
  8. Altmetric Badge
    Chapter 7 HIV Persistence on Antiretroviral Therapy and Barriers to a Cure
  9. Altmetric Badge
    Chapter 8 The Molecular Biology of HIV Latency
  10. Altmetric Badge
    Chapter 9 Cellular Determinants of HIV Persistence on Antiretroviral Therapy
  11. Altmetric Badge
    Chapter 10 In Vitro and In Vivo Models of HIV Latency
  12. Altmetric Badge
    Chapter 11 Measuring HIV Persistence on Antiretroviral Therapy
  13. Altmetric Badge
    Chapter 12 Clinical Interventions in HIV Cure Research
Attention for Chapter 6: Treatment of HIV for the Prevention of Transmission in Discordant Couples and at the Population Level
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
120 Mendeley
Summary X Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Treatment of HIV for the Prevention of Transmission in Discordant Couples and at the Population Level
Chapter number 6
Book title
HIV Vaccines and Cure
Published in
Advances in experimental medicine and biology, January 2018
DOI 10.1007/978-981-13-0484-2_6
Pubmed ID
30030792
Book ISBNs
978-9-81-130483-5, 978-9-81-130484-2
Authors

M. Kumi Smith, Britta L. Jewell, Timothy B. Hallett, Myron S. Cohen, Kumi Smith, M., Jewell, Britta L., Hallett, Timothy B., Cohen, Myron S.

Abstract

The scientific breakthrough proving that antiretroviral therapy (ART) can halt heterosexual HIV transmission came in the form of a landmark clinical trial conducted among serodiscordant couples. Study findings immediately informed global recommendations for the use of treatment as prevention in serodiscordant couples. The extent to which these findings are generalizable to other key populations or to groups exposed to HIV through nonsexual transmission routes (i.e., anal intercourse or unsafe injection of drugs) has since driven a large body of research. This review explores the history of HIV research in serodiscordant couples, the implications for management of couples, subsequent research on treatment as prevention in other key populations, and challenges in community implementation of these strategies.

View on publisher site
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
 Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 120 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 18%
Student > Master 15 13%
Researcher 11 9%
Student > Ph. D. Student 11 9%
Student > Doctoral Student 4 3%
Other 13 11%
Unknown 45 38%
Readers by discipline Count As %
Medicine and Dentistry 28 23%
Nursing and Health Professions 9 8%
Biochemistry, Genetics and Molecular Biology 7 6%
Immunology and Microbiology 5 4%
Psychology 5 4%
Other 15 13%
Unknown 51 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2018.
All research outputs
#20,527,576
of 23,096,849 outputs
Outputs from Advances in experimental medicine and biology
#4,003
of 4,976 outputs
Outputs of similar age
#378,510
of 442,670 outputs
Outputs of similar age from Advances in experimental medicine and biology
#197
of 237 outputs
Altmetric has tracked 23,096,849 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,976 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,670 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 237 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.

This page is provided by Altmetric.